Safety of angiotensin-converting enzyme inhibitors in patients with bilateral renal artery stenosis following successful renal artery stent revascularization

American Journal of Therapeutics

Volumn 13, Issue 4, 2006, Pages 306-308

  Khosla, Sandeep ^a,b   Ahmed, Aziz ^a   Siddiqui, Mumtaz ^a   Trivedi, Atul ^a   Benatar, Daniel ^a   Salem, Yasser ^a   Elbzour, Monther ^a   Vidyarthi, Vasundhra ^a   Lubell, David ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

ACE inhibitors; Renal hypertension; Renovascular disease; Stent

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; LISINOPRIL; NITRATE; VALSARTAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DIABETES MELLITUS; DRUG INDICATION; DRUG SAFETY; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY ARTERY STENT; KIDNEY FAILURE; MAINTENANCE THERAPY; MALE; NONSURGICAL INVASIVE THERAPY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; STENT; STENT REVASCULARIZATION; TREATMENT DURATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; COUGH; FEMALE; HUMANS; HYDRALAZINE; MALE; MIDDLE AGED; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; STENTS; VASCULAR SURGICAL PROCEDURES;

EID: 33749332033     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200607000-00005     Document Type: Article

References (17)

1. Schoolwerth AC, Sica DA, Ballermann BJ, et al. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation. 2001;104:1985-1991.
2. Textor SC. Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol. 1997;17:67-76.
3. Hricik DE, Dunn MJ. Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses. J Am Soc Nephrol. 1990;1:845-858.
4. Mujais SK, Fouad FM, Textor SC, et al. Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. Br Heart J. 1984;52:63-71.
5. Shekelle PG, Rich MW, Morton SC, et al. Efficacy of angiotensin- converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol. 2003;41:1529-1538.
6. McCullough PA, Sandberg KR, Yee J, et al. Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease. Renin Angiotensin Aldosterone Syst. 2002;3:188-191.
7. Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc. 2002;50:1297-1300.
8. Ahmed A, Kiefe CI, Allman RM, et al. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. J Am Geriatr Soc. 2002;50:1659-1666.
9. Geroulakos G, Missouris C, Mitchell A, et al. Endovascular treatment of renal artery stenosis. J Endovasc Ther. 2001;8:177-185.
10. Khosla S, Kunjummen B, Manda R, et al. Prevalence of renal artery stenosis requiring revascularization in patients initially referred for coronary angiography. Catheter Cardiovasc Interv. 2003;58:400-403.
11. Dorros G, Jaff M, Mathiak L, et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv. 2002;55:182-188.
12. Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med. 2001;52:421-442.
13. Bush RL, Martin LG, Lin PH, et al. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney. Ann Vasc Surg. 2001;15:60-66.
14. Hoffman O, Carreres T, Sapoval MR, et al. Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol. 1998;9:65-73.
15. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
16. Khosla S, White CJ, Collins IT, et al. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. J Am Cardiol. 1997;80:363-366.
17. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl Med. 1991;325:303-310.